Immuno-oncology
EPO upholds Compugen patent for immunotherapy cancer treatment
Drug discovery company Compugen has successfully defended a key patent, which covers anti-PVRIG antibodies used in immunotherapy based cancer treatmen
...
17 July 2023 by Amy Sandys